Spots Global Cancer Trial Database for A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours
Official Title: A Phase Ib Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours
Study ID: NCT03082053
Study Description
Brief Summary: The purpose of this study is to explore safety and efficacy of varlitinib administered as monotherapy in Japanese subjects with advanced or metastatic solid tumors, and administered as combination with capecitabine in Japanese subjects with advanced or metastatic biliary tract cancer. Also to evaluate pharmacokinetics (PK) of varlitinib, capecitabine and its metabolite.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
ASLAN Selected sites, Tokyo, , Japan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
